Courtney T S Kureshi (Courtney T Stump)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 11

Top Topics

Prognostic Factors

High Throughput

Top Venues

The Journal of experimental medicine

Journal of immunology (Baltimore, Md. : 1950)

Science advances

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Lestat R Ali, Ana Christina Garrido-Castro, Patrick J Lenehan, Naima Bollenrucher, Courtney T S Kureshi, Michael L Dougan, Shom Goel, Geoffrey I Shapiro, Sara M Tolaney, Stephanie K Dougan
PD-1 blockade and CDK4/6 inhibition augment nonoverlapping features of T cell activation in cancer. The Journal of experimental medicine 220 (4) (2023)
Katherine S Ventre, Kevin Roehle, Elisa Bello, Aladdin M Bhuiyan, Tamara Biary, Stephanie J Crowley, Patrick T Bruck, Max Heckler, Patrick J Lenehan, Lestat R Ali, Courtney T S Kureshi, Victoria Lippert, Eleanor Clancy-Thompson, Winiffer D Conce Alberto, Megan T Hoffman, Li Qiang, Marc Pelletier, James J Akin, Michael Dougan, Stephanie K Dougan
cIAP1/2 Antagonism Induces Antigen-Specific T Cell-Dependent Immunity. Journal of immunology (Baltimore, Md. : 1950) 210 (7) (2023)
Katherine S Ventre, Kevin Roehle, Elisa Bello, Aladdin M Bhuiyan, Tamara Biary, Stephanie J Crowley, Patrick T Bruck, Max Heckler, Patrick J Lenehan, Lestat R Ali, Courtney T S Kureshi, Victoria Lippert, Eleanor Clancy-Thompson, Winiffer D Conce Alberto, Megan T Hoffman, Li Qiang, Marc Pelletier, James J Akin, Michael Dougan, Stephanie K Dougan
cIAP1/2 Antagonism Induces Antigen-Specific T Cell-Dependent Immunity. Journal of immunology (Baltimore, Md. : 1950) (2023)
Rakeeb Kureshi, Elisa Bello, Courtney T S Kureshi, Michael J Walsh, Victoria Lippert, Megan T Hoffman, Michael Dougan, Tyler Longmire, Michael Wichroski, Stephanie K Dougan
DGKα/ζ inhibition lowers the TCR affinity threshold and potentiates antitumor immunity. Science advances 9 (47) (2023)
Lestat R Ali, Ana Christina Garrido-Castro, Patrick J Lenehan, Naima Bollenrucher, Courtney T S Kureshi, Michael L Dougan, Shom Goel, Geoffrey I Shapiro, Sara M Tolaney, Stephanie K Dougan
PD-1 blockade and CDK4/6 inhibition augment nonoverlapping features of T cell activation in cancer. The Journal of experimental medicine 220 (4) (2023)
Lestat R Ali, Ana Christina Garrido-Castro, Patrick J Lenehan, Naima Bollenrucher, Courtney T S Kureshi, Michael L Dougan, Shom Goel, Geoffrey I Shapiro, Sara M Tolaney, Stephanie K Dougan
PD-1 blockade and CDK4/6 inhibition augment nonoverlapping features of T cell activation in cancer. The Journal of experimental medicine 220 (4) (2023)
Katherine S Ventre, Kevin Roehle, Elisa Bello, Aladdin M Bhuiyan, Tamara Biary, Stephanie J Crowley, Patrick T Bruck, Max Heckler, Patrick J Lenehan, Lestat R Ali, Courtney T S Kureshi, Victoria Lippert, Eleanor Clancy-Thompson, Winiffer D Conce Alberto, Megan T Hoffman, Li Qiang, Marc Pelletier, James J Akin, Michael Dougan, Stephanie K Dougan
cIAP1/2 Antagonism Induces Antigen-Specific T Cell-Dependent Immunity. Journal of immunology (Baltimore, Md. : 1950) 210 (7) (2023)
Lestat R Ali, Ana Christina Garrido-Castro, Patrick J Lenehan, Naima Bollenrucher, Courtney T S Kureshi, Michael L Dougan, Shom Goel, Geoffrey I Shapiro, Sara M Tolaney, Stephanie K Dougan
PD-1 blockade and CDK4/6 inhibition augment nonoverlapping features of T cell activation in cancer. The Journal of experimental medicine 220 (4) (2023)
Lestat R Ali, Ana Christina Garrido-Castro, Patrick J Lenehan, Naima Bollenrucher, Courtney T S Kureshi, Michael L Dougan, Shom Goel, Geoffrey I Shapiro, Sara M Tolaney, Stephanie K Dougan
PD-1 blockade and CDK4/6 inhibition augment nonoverlapping features of T cell activation in cancer. The Journal of experimental medicine 220 (4) (2023)
Lestat R Ali, Ana Christina Garrido-Castro, Patrick J Lenehan, Naima Bollenrucher, Courtney T S Kureshi, Michael L Dougan, Shom Goel, Geoffrey I Shapiro, Sara M Tolaney, Stephanie K Dougan
PD-1 blockade and CDK4/6 inhibition augment nonoverlapping features of T cell activation in cancer. The Journal of experimental medicine 220 (4) (2023)
Kevin Roehle, Li Qiang, Katherine S Ventre, Daniel Heid, Lestat R Ali, Patrick J Lenehan, Max Heckler, Stephanie J Crowley, Courtney T S Kureshi, Gabrielle Ro, Anže Godicelj, M Aladdin Bhuiyan, Annan Yang, Maria Quiles Del Rey, Tamara Biary, Adrienne M Luoma, Patrick T Bruck, Jana F Tegethoff, Svenja L Nopper, Jinyang Li, Katelyn T Byrne, Marc Pelletier, Kai W Wucherpfennig, Ben Z Stanger, James J Akin, Joseph D Mancias, Judith Agudo, Michael Dougan, Stephanie K Dougan
cIAP1/2 antagonism eliminates MHC class I-negative tumors through T cell-dependent reprogramming of mononuclear phagocytes. Science translational medicine 13 (594) (2021)